A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2001
11/28/2001	CN1075380C Medicine for enuresis
11/28/2001	CN1075375C Compounds with progesterone-antagonistic and anti-oestrogen properties intended from combined use in female contraception
11/27/2001	US6323204 Analgesics, antiinflammatory agents and antiischemic agents
11/27/2001	CA2083286C Recombinant fibrinogenases, preparation and use thereof
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087841A1 Novel polymorph v of torasemide
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087836A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
11/22/2001	WO2001087835A1 Α crystalline form of perindopril tert-butylamine salt
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087329A1 Liquid pharmaceutical composition containing an erythropoietin derivate
11/22/2001	WO2001087294A1 Phosphate transport inhibitors
11/22/2001	WO2001087265A2 Pharmaceutical form of administration for peptides, methods for its production and use
11/22/2001	WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001	WO2001037862A3 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001030324A3 Use of acetylsalicylic acid and a preparation for treatment of prostatic hyperplasia
11/22/2001	US20010044459 Hydroxamic acid derivatives
11/22/2001	US20010044441 And female sexual dysfunction, premature labour or dysmenorrhea
11/22/2001	US20010044438 Combination of specific alpha-adrenoceptor antagonists and muscarinic antagonists is administered simultaneously, separately or sequentially to treat the lower urinary tract symptoms associated with benign prostate hyperplasia
11/22/2001	DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001	DE10020667A1 Neue Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln New benzoxazine and benzothiazine derivatives and their use in medicaments
11/22/2001	CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001	CA2409699A1 Novel polymorph v of torasemide
11/22/2001	CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408667A1 Phosphate transport inhibitors
11/22/2001	CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1155691A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155690A2 Anti-angiogenic compositions and method of use
11/21/2001	EP1155689A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155304A2 A system for cell-based screening
11/21/2001	EP1155003A1 Novel guanidine derivatives as inhibitors of cell adhesion
11/21/2001	EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001	EP1154988A1 Mevinolin derivatives
11/21/2001	EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001	EP0998292B1 Method for inhibiting bone resorption
11/21/2001	EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001	EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
11/21/2001	CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001	CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001	CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1323165A Protein material for slow digestion and its use
11/21/2001	CN1322530A Niaoshijiang as medicine for preventing and treating urinary tract infection
11/21/2001	CN1322474A Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process
11/20/2001	US6320054 Thiazole derivatives
11/20/2001	US6319938 Prophylactic or therapeutic drug for renal diseases
11/20/2001	US6319934 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
11/20/2001	US6319920 Muscarinic receptor antagonist used in gastrointestinal, genitourinary tract, respiratory tract, cardiovascular system, central nervous system disorders and in anesthesiology and ophthalmology
11/20/2001	US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001	CA2053864C Modified forms of reproductive hormones
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085763A2 Chimeric peptide immunogens their preparation and use
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001	WO2001085256A2 Critical illness neuropathy
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085194A1 Method and composition for the treatment of angiogenesis
11/15/2001	WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001	WO2001085147A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
11/15/2001	WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001	WO2000050872A9 A system for cell-based screening
11/15/2001	US20010041729 Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	US20010041711 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazospiro(4.5) decan-4-one, for example; treating pain with reduced side effects of opioid analgesics; affinity for opioid receptor-like (ORL1) receptor
11/15/2001	US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001	US20010041695 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of L-carnitine or salts
11/15/2001	US20010041191 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate
11/15/2001	US20010041189 Dipeptide containing glutamic acid
11/15/2001	DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
11/15/2001	CA2691739A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo [b]thiophene and salts thereof
11/15/2001	CA2409759A1 Method and composition for the treatment of angiogenesis
11/15/2001	CA2408563A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
11/15/2001	CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407886A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001	CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/15/2001	CA2407830A1 Amino acid derivatives and their use as medicines

1 ... 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 ... 562